← Research library

EMERCOM proceedings: four drugs in a 217 km military field exercise

Comparison in people · 2016

What was studied
320 Belarusian contract servicemen, mean age 21.3, across four treatment groups and placebo.
Main finding
During a 217 km, seven-day exercise, the authors report faster recovery with Metaprot and higher circulatory and respiratory reserves with Cortexin.

Related evidence maps: Military & occupational ↗

Reported findings and study design

During a 217 km, seven-day exercise, the authors report faster recovery with Metaprot and higher circulatory and respiratory reserves with Cortexin.

Measurements before the exercise, within 24 hours after return, and three days later. Informed consent and ethics committee approval were reported.

Population or model 320 Belarusian contract servicemen, mean age 21.3, across four treatment groups and placebo.

Dose, route and schedule

A 14-day course began one week before the exercise. Cortexin was reported as 0.4 mg intranasally twice daily. Metaprot, Cytoflavin and Gliatilin were each reported as two tablets twice daily. Tablet strengths and placebo dosing were unspecified.

Protocol source ↗ · Complete institutional conference abstract; printed pp. 172–173.

Results · Complete institutional conference abstract; printed pp. 172–173.
MeasureResultComparison, timing and statistics
Metaprot and Cytoflavin · recoveryFaster recovery describedCytoflavin response was strongest in selected TFAM, PPARA and PPARGC1A genotype groups.
Cortexin · circulation and respirationHigher physiological reserves describedNo effect on recovery or basal metabolism was reported.
Gliatilin · mobility of nervous processesImprovement describedNo effect on physiological reserves or basal metabolism was reported.
Conference abstract · treatment arms
Conference abstract · treatment arms
GroupnReported administration
Metaprot (Bemitil)61Two tablets twice daily
Cytoflavin63Two tablets twice daily
Cortexin650.4 mg intranasally twice daily
Gliatilin66Two tablets twice daily
Placebo65Schedule unspecified

This is a companion report to Pyatibrat’s dissertation. The field exercise contributes no additional participant records.

Source for these results ↗ · Reviewed 2026-11-17

Study limitations and source details

Study limitations

  • The abstract gives no effect sizes, allocation or masking details, or adverse-event counts.
  • The five arms sum to 320. The dissertation reports 570 overall and Table 49 tabulates 310, including 55 in the Cortexin arm versus 65 here.

Related publications may describe some of the same participants or experiments.

Source details

Original conference abstract · Complete institutional conference abstract; printed pp. 172–173.

Complete institutional conference abstract; printed pp. 172–173.

Reported methods, results and evidence limitations

Sources checked

Added to the library

Citation

Human comparative studyFull text available

A. O. Pyatibrat, S. B. Melnov, E. D. Pyatibrat, P. D. Shabanov. EMERCOM proceedings: four drugs in a 217 km military field exercise Multidisciplinary Clinic of the 21st Century, St Petersburg congress proceedings, pp. 172–173

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards